Primary record
Valsartan Methyl Ester; Valsartan Related Compound E (USP); N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine methyl ester; Valsartan Related Compound E
- 库存
- 6,285 克
- 纯度
- 99.2 %
- CAS
- 137863-17-3
化合物标识与属性
- CAS
- 137863-17-3
- PubChem CID
- 11561462
- SMILES
- CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)OC
- Canonical SMILES
- CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@H](C(=O)OC)C(C)C
名称与同义词
- valsartan methyl ester
- 137863-17-3
- Valsartan impurity E
- Valsartan Related Compound E
- (S)-Methyl 2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- 7BZQ418Z0J
- UNII-7BZQ418Z0J
- RefChem:1090817
- SCHEMBL2251
- CHEMBL326349
- CGP 48933 methyl ester
- Valsartan impurity E [USP-MC]
- C25H31N5O3
- orb1685563
- SCHEMBL21619424
- SCHEMBL29669823
- CTK8C0950
- DTXSID50468616
- MFCD31562813
- UJTNRXYTECQKFO-QHCPKHFHSA-N
- Valsartan USP Related Compound E
- 6620AA
- ANW-65515
- BDBM50282365
- MFCD17215380
- NP3680
- ZINC27079783
- AKOS015899737
- AKOS037647709
- VALSARTAN METHYL ESTER IMPURITY
- CS-O-10333
- HY-W414915
- CID11561462
- AS-74538
- SC-44898
- N-(1-Oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-L-valine methyl ester
- TC-154260
- CS-0515136
- ST24036315
- J2.104.940I
- VALSARTAN RELATED COMPOUND E [USP-RS]
- D92869
- Methyl (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoate
- A886382
- L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, methyl ester
- I14-11666
- Q27268035
- Valsartan Related Compound E; Valsartan Methyl Ester
- L-Valine, N-(1-oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, methyl ester
- METHYL (2S)-3-METHYL-2-(N-{[2'-(2H-1,2,3,4-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL]METHYL}PENTANAMIDO)BUTANOATE
- N-[2 inverted exclamation mark -(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine methyl ester
- methyl N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valinate
- Methyl N-pentanoyl-N-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valinate
- N-[2 inverted exclamation mark -(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Va
- N-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine methyl ester
- N-[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl methyl]-N-valeryl-(L)-valine methyl ester 1g
- N-[2-(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine methyl ester
- N-valeryl-N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]-(L)-valine methyl ester
- (2S)-2-[Pentanoyl[[2 -(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]-3-methylbutyric acid methyl ester
- (S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid methyl ester
- (S)-Methyl2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoate
- L-Valine,N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,methylester
- METHYL (2S)-3-METHYL-2-(N-{[2'-(1H-1,2,3,4-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL]METHYL}PENTANAMIDO)BUTANOATE
- methyl (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoate
- N-[2 inverted exclamation mark -(1H-tetrazol-5-yl)biphenyl-4-yl methyl]-N-Valeryl-(L)-Valine methyl ester
- Valsartan Methyl Ester; Valsartan Related Compound E (USP); N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine methyl ester; Valsartan Related Compound E